OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer
In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine ...
Source: marketscreener.com